Related by context. All words. (Click for frequent words.) 70 CHMP 69 European Medicines Evaluation 66 Medicinal Products 62 Medicinal Products EMEA 61 Human Use CHMP 61 CHMP opinion 61 Human Medicinal Products 61 Focetria 60 Marketing Authorization Application 60 Swissmedic 59 Marketing Authorization 59 Marketing Authorisation Application 59 CHMP recommendation 58 Centralized Procedure 58 Replagal 58 FDA 58 Tyverb 57 Marketing Authorization Application MAA 57 cervical cancer vaccine Cervarix 57 Revolade 57 approvable letters 57 Zalbin 57 Marketing Authorization Applications 57 Drug Administration 56 Saphris 56 Drug Administration FDA 56 Xyrem ® 56 Scientific Advice 56 Sebivo 56 JOULFERON 56 Arzerra 56 FDA Oncologic Drugs 56 RoActemra 56 OMP designation 56 Proprietary Medicinal Products CPMP 55 Voraxaze 55 Avastin bevacizumab 55 Rasilez HCT 55 Vpriv 55 Seroquel XR 55 Cladribine 55 Application MAA 55 Prexige 55 Humenza 55 Alitretinoin 55 Orathecin 55 orphan medicinal product 55 Tysabri natalizumab 55 Junovan 55 Marketing Authorisation 55 Clolar 54 Mepact 54 Orphan Medicinal Products 54 Fampyra 54 Orphan Drug status 54 Safety Authority EFSA 54 Certican 54 Promacta 54 Adenuric R 54 Pixuvri 54 DCGI 54 Esbriet pirfenidone 54 Tasigna nilotinib 54 Acomplia 54 orphan designation 54 Raptiva R 54 Movectro 54 Vasovist 54 Telzir 54 NOXAFIL 54 blood thinner prasugrel 54 CERVARIX R 54 ceftobiprole 54 Torisel 54 Rasilamlo 54 FDA Antiviral Drugs 54 Nexavar sorafenib 54 Myfortic 54 Romiplostim 53 ezogabine 53 Orphan Medicinal Product 53 orphan medicinal 53 Joulferon 53 Sanofi aventis EURONEXT SAN 53 Nebido 53 ATryn 53 Pirfenidone 53 Brilique 53 USFDA 53 Fablyn 53 vaccine Cervarix 53 CELVAPAN H#N# 53 Fortigel 53 FDA Anti Infective 53 Esbriet 53 Rhucin ® 53 Final Appraisal Determination 53 Eucreas 53 Rotarix vaccine 53 Gilenia 53 Neupro 53 Victoza liraglutide 53 Febuxostat 53 Arzerra ofatumumab 53 Rebetol 53 Tygacil 53 Actemra 53 Onglyza 53 Positive Opinion 53 Oncologic Drugs Advisory 53 Pegintron 53 guanfacine extended release 53 Ceflatonin 53 Metabolic Drugs Advisory 53 NASDAQ SHPGY TSX SHQ 53 AstraZeneca Iressa 53 Centralised Procedure 53 Gene Therapy Advisory 53 Application BLA 53 Medicines Consortium 53 Entereg 53 Drug Administration USFDA 53 Esbriet ® 53 Uplyso 53 supplemental biologics 52 Relistor 52 Celsentri 52 GSK Avandia 52 Glybera R 52 AZILECT R 52 Decentralized Procedure DCP 52 Receives Positive Opinion 52 Decentralized Procedure 52 Teysuno 52 Cerepro 52 Auxilium Pharma 52 Ceftobiprole 52 Exanta 52 vinflunine 52 Onglyza saxagliptin 52 Prexige lumiracoxib 52 Vectibix panitumumab 52 TEMODAL 52 motavizumab 52 Sycrest 52 vemurafenib 52 Zimulti 52 Pulmonary Allergy Drugs 52 Ruconest 52 Rhucin R 52 Civacir 52 PegIntron 52 Actemra tocilizumab 52 Galvus 52 Neupro R 52 Plicera 52 taliglucerase alfa 52 Shire plc 52 India DCGI 52 Lilly Cymbalta 52 Kynapid 52 Dacogen injection 52 Prepandrix 52 Icatibant 52 Velaglucerase Alfa 52 Biologic License Application BLA 52 pirfenidone 52 ZALBIN 52 Proprietary Medicinal Products 52 Tykerb 52 FDA Endocrinologic 52 Vertex telaprevir 52 Noxafil 52 Ixempra 52 submitted Marketing Authorization 52 Erwinase 52 Firdapse ™ amifampridine phosphate 52 Cimzia 52 Omapro 52 Martin Harvey Allchurch 51 Zenpep 51 Firazyr 51 Trobalt 51 Exelon rivastigmine 51 Daxas 51 Neupro ® 51 midstage studies 51 SEBIVO 51 Doribax 51 FDA Dermatologic 51 Tekturna HCT 51 Fodosine 51 FIRAZYR 51 Roche Holding AG ROG.VX 51 Omnitrope 51 FDA Approvable Letter 51 Xarelto 51 alogliptin 51 Mycamine 51 Mirapexin 51 Increlex R 51 Factive 51 New Drug Application 51 alvimopan 51 ONGLYZA ™ 51 Drug Administration Oncologic Drugs 51 EFSA 51 EGRIFTA TM 51 FDA Advisory Panel 51 GTC recombinant human 51 Toctino ® alitretinoin 51 MAA submission 51 Vimpat 51 velaglucerase alfa 51 NASDAQ SHPGY 51 ELIQUIS 51 Zavesca 51 Arixtra 51 Serdolect 51 sorafenib tablets 51 bazedoxifene 51 Metabolic Drugs 51 supplemental Biologics License Application 51 Raptiva ® 51 Vimovo 51 Silenor ® doxepin 51 Merck Arcoxia 51 Shire Pharmaceuticals Group 51 efalizumab 51 Diamyd r 51 Orphan Drug Designation 51 Biologic License Application 51 Japanese Encephalitis vaccine 51 Keppra ® levetiracetam 51 Telavancin 51 Mycograb 51 Novartis Prexige 51 Ceplene 51 Arthritis Advisory 51 Novartis AG NOVN.VX 51 etanercept Enbrel 51 Fast Track Status 51 Orphan Drug Status 51 painkiller Prexige 51 Toctino R 51 Anti Infective Drugs 51 UCB Cimzia 51 HPV vaccine Cervarix 51 Zyflo CR 51 human antithrombin 51 cladribine 51 mifamurtide 51 Rotarix 51 vaccine Synflorix 51 Afinitor ® 51 Mutual Recognition Procedure 51 Sutent 51 CytoFab 51 CDP# 51 Botox Botox Cosmetic 51 Removab 51 Tredaptive 51 Ceplene R 51 Mircera 51 Cimzia certolizumab pegol 51 Hycamtin 51 Orexigen Contrave 51 Alimta pemetrexed 51 Eloxatin ® 50 Luveris 50 VPRIV 50 Canvaxin 50 Bridion 50 Fusilev 50 Plenaxis R 50 FDA Pulmonary Allergy 50 Vimpat ® lacosamide 50 Toctino ® 50 AstraZeneca AZN 50 Clinical Trial Application 50 Provenge prostate cancer 50 Vidaza azacitidine 50 Votrient 50 Alvesco 50 Administration TGA 50 Swiss drugmaker 50 rilonacept 50 Xarelto rivaroxaban 50 Barr ANDA 50 Sanofi Acomplia 50 Drug Administration FDA Oncologic 50 Hexvix 50 Drug Submission 50 Zyflo 50 Intelence 50 NEBIDO 50 Rasagiline 50 ANTEGREN 50 Bonefos 50 Jevtana 50 vaccine Pandemrix 50 MHLW 50 eprodisate KIACTA TM 50 Rimonabant 50 Satraplatin 50 KINRIX 50 aripiprazole Abilify 50 Basilea Toctino R 50 Roche Holding AG RHHBY 50 albinterferon alfa 2b 50 Orphan Drug designation 50 Metformin GR 50 Pandemrix 50 Horizant 50 approvability 50 Forsteo 50 GlaxoSmithKline Plc GSK.L Quote 50 Antiviral Drugs Advisory 50 liver resection surgeries 50 CONBRIZA 50 Torisel temsirolimus 50 Trovax 50 Bifeprunox 50 Praecis 50 oral ridaforolimus 50 amifampridine phosphate 50 Arranon 50 orphan drug 50 CNTO 50 Clevudine 50 Rhucin 50 Advexin 50 Vion Pharmaceuticals 50 MEPACT 50 Lambert Eaton Myasthenic 50 Clinical Excellence NICE 50 Viviant 50 Berinert 50 Onbrez Breezhaler 50 Serdolect ® 50 bevacizumab Avastin 50 Alogliptin 50 severe hypercholesterolemia 50 pregabalin Lyrica 50 Extavia 50 Fluarix 50 CIMZIA r 50 pancreatic enzyme replacement 50 Phase III clinical 50 sBLA 50 Aridol 50 Novartis AG Galvus 50 Ambrisentan 50 Jerini 50 donepezil rivastigmine 50 OPAXIO 50 Evoltra TM 50 Bydureon 50 FDA Psychopharmacologic Drugs 50 Board DSMB 50 Modrenal R 50 COMFORT II 50 #D#C# 50 Loramyc R 50 Biologics License Application BLA 50 Sparlon 50 Zactima 50 Phase III Clinical Trials 50 Reminyl galantamine 50 Afinitor 50 abatacept Orencia 50 Potiga 50 CDER 50 PrevOnco 50 Cervarix 50 Ticagrelor 50 Intuniv 49 gepirone ER 49 Valtropin 49 SkyePharma Plc 49 Aviptadil 49 MHRA 49 Multaq 49 Serevent 49 Nplate 49 Betaferon 49 romiplostim 49 Fosrenol 49 SYCREST 49 Therapeutic Goods Administration TGA 49 Edurant 49 sNDA 49 Marketing Authorisation Application MAA 49 Ocrelizumab 49 Rotarix R 49 roflumilast 49 Fingolimod 49 FOLOTYN ® 49 Vitaros 49 Reclast Aclasta 49 sitaxsentan sodium 49 Somatuline Depot 49 Receives Marketing Authorization 49 TWYNSTA ® 49 approvable letter 49 Peginterferon alfa 2b 49 paliperidone palmitate 49 GSK 49 Riluzole 49 AFSSAPS 49 Tyvaso 49 DC Bead 49 Roche Actemra 49 Nexavar tablets 49 FDA approvable letter 49 Pfizer Sutent 49 Roflumilast 49 ImClone Erbitux 49 Krystexxa 49 Dalbavancin 49 promote ceftobiprole 49 Tekamlo 49 Protopic 49 Pfizer maraviroc 49 Cellegesic 49 Accolate 49 Adcirca 49 Onsolis 49 Fortovase 49 DORIBAX 49 Uloric 49 fluvoxamine maleate 49 Biologics License Application 49 Vectibix 49 Emend 49 ZEFTERA TM 49 Taxotere docetaxel 49 ELAPRASE 49 Egrifta 49 Pulminiq 49 TORISEL TM 49 Santhera 49 AVASTIN 49 PROMACTA 49 Amyvid 49 SWX BSLN 49 donepezil hydrochloride 49 Clofarabine 49 Avelox 49 Alvesco R 49 asenapine 49 Revlimid lenalidomide 49 rheumatoid arthritis psoriatic arthritis 49 methylnaltrexone bromide 49 Exforge HCT 49 Viracept 49 Vandetanib 49 StaphVAX R 49 Zytiga 49 Orphan Status 49 Intravenous Hepatitis B 49 Daliresp 49 ocrelizumab 49 Azathioprine 49 submitted Biologics License 49 Biologics Licensing 49 Adenuric 49 pralatrexate 49 cetuximab Erbitux 49 Dynepo 49 granted Ortec 49 Glybera 49 Grazax 49 plc LSE SHP 49 fingolimod 49 Nivestim 49 clofarabine 49 Advagraf 49 Retacrit 49 Vimpat lacosamide 49 Bronchitol 49 BfArM 49 investigational hepatitis B 49 BENLYSTA 49 Stavzor 49 Soliris TM eculizumab 49 pediatric glioma 49 GlaxoSmithKline Biologicals 49 peginesatide 49 Novartis VIRT X 49 muraglitazar 49 telbivudine 49 Intermezzo ® NDA 49 Cimzia ® 49 TYGACIL 49 Australian Therapeutic Goods 49 clinical trial 49 Phase III clinical trials 49 GlaxoSmithKline GSK 49 sublingual tablets 49 Orphan Designation 49 Alemtuzumab 49 Oglemilast 49 antibiotic ceftobiprole 49 AstraZeneca Toprol XL 49 lorcaserin NDA 49 Orazol 49 OMAPRO ™ 49 Roche PEGASYS R 49 BLA filing 49 Medicines Agency 49 Calcium Acetate 49 Sanofi Aventis Acomplia 49 Therapeutic Products 49 MHRA Medicines 49 MAGE A3 ASCI 49 Aflunov 49 atypical antipsychotic medication 49 GlaxoSmithKline PLC 49 Dulera 49 Prezista 49 Orphan designation 49 ATryn ® GTC recombinant 49 Therapeutic Goods Administration 49 silodosin 49 Tibotec Pharmaceuticals Ltd. 49 Velcade bortezomib 49 Expanded Indication 49 Mimpara 49 YONDELIS R 49 Augment Bone Graft 49 Aptivus 49 Restoraderm R 49 Dasatinib 49 Celgene Revlimid 49 BARACLUDE R 49 Sutent sunitinib malate 49 ANDA Filing 49 Mylotarg 49 Drug Application 49 Pivotal Phase III 49 ixabepilone 49 Nasdaq OSCI 49 SNT MC# 49 PDUFA Date 49 Syndrome LEMS 49 Nexavar 49 GlaxoSmithKline GSK.L 49 Vibativ 49 rolling Biologics License 49 eltrombopag 48 Product Characteristics 48 UPLYSO 48 Immunization Practices ACIP 48 Shire PLC 48 Celebrex celecoxib 48 Tekturna aliskiren 48 Certriad 48 Relenza zanamivir 48 Flutiform ™ 48 ACCLAIM II 48 Cefprozil 48 Nasdaq ONXX today 48 Clinical Excellence Nice 48 Drug Eluting Stent System 48 ATRIPLA TM 48 Femara letrozole 48 aztreonam lysine 48 tocilizumab 48 TYKERB 48 Contrave 48 blood clot preventer 48 panitumumab Vectibix 48 Trexima 48 Belimumab 48 BLA submission 48 SUMAVEL DosePro 48 ECVAM 48 Hematide ™ peginesatide 48 Xinlay 48 Avandia rosiglitazone 48 aleglitazar 48 Lumiracoxib 48 injectable antibiotic 48 Market Authorization Application 48 indacaterol 48 Afinitor everolimus 48 Cancidas 48 generic Lovenox 48 Starlix 48 RELISTOR ® 48 Panzem R 48 Amigal 48 Tostran 48 MK #B 48 Angiox 48 Xigris 48 TYZEKA 48 QNEXA ® 48 Lenalidomide 48 investigational compound 48 REVLIMID lenalidomide 48 Preos 48 Tetrabenazine 48 SIMPONI TM 48 FDA Accepts 48 Novartis AG NVS 48 metoprolol succinate 48 aflibercept 48 Invirase 48 GARDASIL ® 48 Loramyc 48 NYSE AMEX PLX 48 MyVax R 48 SUBOXONE 48 Zelmac 48 Sutent sunitinib 48 Lorqess 48 PrandiMet 48 antidepressant Serzone 48 refractory chronic lymphocytic 48 Onrigin 48 Rapydan 48 Loramyc ® 48 Sprycel 48 RoACTEMRA 48 Preotact 48 vaccine RotaTeq 48 Linjeta TM 48 Resolor 48 myelodysplastic myeloproliferative diseases 48 Vivus Qnexa 48 Azilect ® 48 Glaxo Cervarix 48 Lodotra 48 Anidulafungin 48 Sprycel dasatinib 48 Keppra ® 48 Peramivir 48 hypereosinophilic syndrome 48 CELVAPAN 48 Hiberix 48 FDA Complete Response 48 GlaxoSmithKline Rotarix 48 Losec 48 Paxil paroxetine 48 Ranexa 48 ALVESCO R 48 rotavirus vaccine Rotarix 48 ACOMPLIA R 48 atovaquone 48 Arxxant 48 casopitant 48 MEZAVANT 48 obesity pill Acomplia 48 Ebixa 48 Protalix 48 Victoza 48 Arpida 48 Oracea TM 48 Certolizumab pegol 48 Injectafer 48 satraplatin 48 Xyzal 48 eprodisate Fibrillex TM 48 T Pred 48 Abstral 48 telithromycin 48 STELARA TM 48 Asenapine 48 orBec 48 Somatuline Autogel 48 XGEVA ™ 48 Flutiform 48 Multaq dronedarone 48 Stelara ustekinumab 48 Afrezza 48 vismodegib 48 Carbidopa Levodopa 48 Desvenlafaxine 48 Allergy Therapeutics 48 Ferinject 48 Orphan Drug designations 48 AZILECT ® 48 Uvidem 48 Treximet 48 Liprotamase 48 Hexvix ® 48 Glaxo Advair 48 Diamyd ® 48 StaphVAX 48 etravirine 48 Corlux 48 GlaxoSmithKline PLC GSK 48 Erbitux cetuximab 48 Merck RotaTeq 48 BAY #-# 48 Indiplon 48 FluLaval 48 LSE SHP.L 48 REBETOL combination therapy 48 Yondelis 48 Accelerated Approval 48 neuraminidase inhibitor 48 QAB# 48 Vernakalant 48 vandetanib 48 Fludara ® 48 GlaxoSmithKline Rotarix vaccine 48 GTC recombinant form 48 darbepoetin alfa Aranesp 48 WHO prequalification 48 Antegren 48 LymphoStat B TM 48 Muraglitazar 48 acyclovir Lauriad R 48 Zelrix 48 Cimzia R 48 Humira adalimumab 48 Thelin 48 Sumavel DosePro 48 Pentacel vaccine 48 Clolar ® 48 FTY# 48 Cobalt Pharmaceuticals 48 Tekturna HCT ® 48 Impax ANDA 48 Elvitegravir 48 LSE PFZ 48 AG NVS 48 Bayer Nexavar 48 AstraZeneca Symbicort 48 clinical trials 48 Milnacipran 48 Dexilant 48 inhalable insulin product 48 Daytrana ® 48 biosimilar 48 Selzentry 48 SEROQUEL XR 48 Golimumab 48 indiplon capsules 48 Cerepro ® 48 midstage clinical 48 faropenem medoxomil 48 Prestara 48 BRILINTA 48 Risperidone Oral Solution 48 Exalgo 48 Drug Adminstration 48 Ramelteon 48 Securities Regulators CESR 48 SUTENT ® 48 FASLODEX 48 F.D.A. 48 DASISION 48 Phase IIIb study 48 adalimumab Humira 48 Oracea ® 48 Genetic Engineering Approval 48 Asmanex 48 mesylate tablets 48 naproxen esomeprazole magnesium 48 maraviroc 48 daptomycin 48 methylnaltrexone 48 Fast Track Designation 48 INTELENCE 48 Motavizumab 48 Zelnorm 48 Thalomid 48 candidates Dyloject TM 48 Avastin 48 EllaOne 48 Acomplia rimonabant 48 Novartis Femara 48 Brentuximab Vedotin SGN 48 GlaxoSmithKline Plc GSK.L 48 Paragraph IV Notice 48 Anastrozole 48 Entocort 47 pediatric exclusivity 47 dalbavancin 47 Xolair 47 Increlex 47 pazopanib 47 Protalix BioTherapeutics Inc. 47 post operative ileus 47 Multaq R 47 pemetrexed Alimta 47 Campath ® 47 SHP.L 47 sorafenib tosylate 47 Baxter Celvapan 47 Increlex TM 47 Ciclesonide 47 ORENCIA R 47 rotigotine transdermal patch 47 Apidra 47 BLP# Liposome Vaccine 47 blood clot preventer prasugrel 47 Nexavar ® 47 Voraxaze ™ 47 CryoSeal FS System 47 Aventis SASY.PA 47 AstraZeneca Plc AZN 47 Vernalis plc 47 Exforge 47 SNT-MC#/idebenone 47 Angiox ® 47 Nabi HB Intravenous 47 capsule formulation 47 Sanvar R 47 Tykerb lapatinib 47 Shire Plc 47 balsalazide tablet 47 HFA MDI 47 Cardiome 47 Prestara TM 47 Inhaled insulin 47 Sunovion Pharmaceuticals Inc. 47 Rectogesic 47 Orencia abatacept 47 pill Galvus 47 Relovair 47 BENLYSTA ® 47 Iressa gefitinib 47 myelodysplastic syndromes 47 levetiracetam Keppra 47 Alvesco ® 47 Transkaryotic 47 PDUFA date 47 EGRIFTA 47 licensee AnGes MG 47 Maraviroc 47 Rezonic 47 rimonabant 47 Eribulin 47 cSSTI 47 Increlex ® 47 ADVEXIN 47 Premarket Approval PMA 47 Yondelis ® 47 oral iron chelator 47 THELIN 47 Vyvanse lisdexamfetamine dimesylate 47 Orphan Drug 47 RhuDex 47 Gleevec imatinib mesylate 47 Fx #A 47 Rhucin ® recombinant 47 Istodax 47 gadobutrol 47 Glaxo Tykerb 47 Celvapan 47 PRIALT 47 Kepivance ® 47 ATPace TM 47 Foradil 47 senicapoc 47 IRESSA 47 Cylert 47 APF# NDA 47 R sorafenib tablets 47 Shire Adderall XR 47 Ilaris 47 Human Fertilization 47 Orexigen Therapeutics Inc 47 MabThera rituximab 47 human papillomavirus vaccine Cervarix 47 Accomplia 47 Glycopyrrolate 47 received CE Conformite 47 Myobloc 47 Vimpat R 47 Xelox 47 Xgeva 47 HepaGam B 47 Erbitux 47 Ampligen 47 breast cancer pill Tykerb 47 PREOS 47 Veronate 47 JZP 6 47 Tarceva 47 Regulatory Agency MHRA 47 bioequivalence 47 Taranabant 47 Junovan TM 47 EPAR 47 ZURICH AFX Novartis AG 47 XIAFLEX ™ 47 AstraZeneca Plc 47 ORENCIA ® 47 benfluorex 47 submitted supplemental Biologics 47 rasagiline tablets 47 submitted Marketing Authorisation 47 Panflu TM Sinovac 47 DAYTRANA TM 47 Endocrinologic 47 Pfizer Geodon 47 Zevtera 47 PCV# 47 Clinuvel 47 oxymorphone ER 47 zalutumumab 47 anti inflammatory NSAID 47 BREAKYL 47 Camptosar 47 Adalimumab 47 Roche Avastin 47 Arpida Ltd 47 tramiprosate ALZHEMED TM 47 Not Approvable 47 Orapred ODT 47 Rilutek 47 Veterinary Medicines Directorate VMD 47 Clinical Trial Investigating REOLYSIN 47 Xolegel 47 Zometa zoledronic acid 47 UCB SA 47 Ranolazine 47 Myozyme 47 SkyePharma PLC LSE SKP 47 TAXUS Element Stent System 47 Fluconazole 47 RHHDY 47 alitretinoin 47 Naglazyme 47 Pradaxa 47 eribulin mesylate 47 ofatumumab HuMax CD# 47 Arzerra TM 47 Zensana 47 interferon gamma 1b 47 OMNARIS 47 Tysabri 47 anidulafungin 47 OSI Tarceva 47 febuxostat 47 GATTEX TM 47 Amex PLX 47 Renvela 47 Psychopharmacologic Drugs Advisory 47 tanezumab 47 Keryx Biopharma 47 SCHWARZ PHARMA 47 MyVax 47 AERIUS 47 octagam ® 47 eprotirome 47 commercialize oritavancin 47 REPLAGAL 47 Immunogen 47 EGRIFTA ™ 47 Ceflatonin ® 47 Drug Controller 47 AG NOVN.VX 47 SmPC 47 regadenoson 47 Gastrointestinal Drugs 47 Eraxis 47 Cellcept 47 Complete Response Letter CRL 47 Pivotal Trial 47 ASA# 47 Synvisc One 47 SIX BSLN 47 AstraZeneca AZN.L 47 GlaxoSmithKline plc 47 Regeneron Pharma 47 liprotamase 47 Thalidomide Pharmion 47 manufactures Cervarix 47 Bazedoxifene 47 Symbicort 47 Campath 47 Pharmaxis 47 histamine dihydrochloride 47 RevAssist R 47 Safinamide 47 Clinical Guideline 47 Vilazodone 47 Idenix Pharmaceuticals Inc. 47 Altabax 47 Immunisation JCVI 47 Announces Tentative Approval 47 Rituxan rituximab 47 Cesamet 47 FACTIVE R gemifloxacin 47 Novartis AG Foradil 47 Ophthalmic Drugs Advisory 47 Afluria 47 Keppra XR 47 PCV1 47 Dendreon Provenge 47 gastrointestinal stromal tumors 47 FDAs